.svg){kind=small}
Aug-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow's performance in the Alberta market has shown consistent strength in the Capsules category, maintaining a solid third-place ranking from May to August 2025. However, there was a noticeable decline in sales from July to August, which might indicate a seasonal trend or increased competition. In the Concentrates category, Stigma Grow displayed a positive trajectory, moving from 17th place in May to 14th in August, with a significant sales boost in the latter month. The Flower category, however, saw the brand struggling to make a notable impact, ranking only in July and not appearing in the top 30 for other months.
In British Columbia, Stigma Grow's presence in the Concentrates category improved, moving from 16th in May to 12th in August, suggesting a strengthening foothold in this segment. However, the brand's Capsules were only ranked in May, indicating limited traction in this category. Ontario presented a mixed picture; while the Capsules category saw a slight drop from 9th to 10th place by August, the brand was absent from the Concentrates rankings until August, when it appeared at 46th place, suggesting a late entry or increased competition. This movement across provinces and categories highlights both opportunities and challenges for Stigma Grow in maintaining and expanding its market presence.
Competitive Landscape
In the competitive landscape of the concentrates category in Alberta, Stigma Grow has shown a notable upward trend in recent months. Despite starting at a rank of 17 in May 2025, Stigma Grow improved its position to 14 by August 2025, indicating a positive shift in market presence. This improvement is significant when compared to competitors like 1964 Supply Co, which saw a decline from rank 8 to 11 over the same period. Meanwhile, Pura Vida experienced fluctuations, dropping to rank 16 by August, and Adults Only maintained a relatively stable position, peaking at rank 12 in August. Stigma Grow's sales surge in August, reaching a notable peak, suggests a strengthening consumer preference, potentially driven by strategic marketing or product innovation, setting it apart from competitors who either experienced sales decline or modest growth.
Notable Products
In August 2025, Phoenix Tears RSO (1g) emerged as the top-performing product for Stigma Grow, climbing from its consistent second-place ranking in the previous months to first place, with sales reaching 5,031 units. Indica RSO Capsules 25-Pack (250mg), which had maintained the top rank from May to July, slipped to second place in August. CBD Softgels 15-Pack (750mg CBD) held steady in third place throughout the four-month period. Phoenix Tears Resin (1g) re-entered the rankings in August at the fourth position, having been absent in May and July. Phoenix Tears Honey Oil (1g) maintained a presence in the rankings, holding the fifth position in August after an absence in July.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
